{"id":{"repo_id":"strathclyde","oai_identifier":"oai:strathclyde:d217qq024"},"canonical_url":"https://search.ndltd.org/etd/strathclyde/oai:strathclyde:d217qq024","repository":{"repo_id":"strathclyde","name":"University of Strathclyde","base_url":"https://stax.strath.ac.uk/catalog/oai"},"display":{"title":"The design and synthesis of chemical probes for non-BET bromodomains","abstract":"This thesis describes the design and synthesis of chemical probes for non-BET bromodomains.Studies have shown that inhibition of the BET bromodomains leads to profound activity in immuno-inflammation and oncology disease settings, with several BET bromodomain inhibitors entering the clinic. The validation of this new target class has led to a surge of interest in the remaining 53 non-BET bromodomains. Whilst the majority of non-BET bromodomains have been implicated in disease pathways, the biological role they play in mediating disease states is unknown. To help delineate the function of the non-BET bromodomains in disease, and establish their potential as therapeutic targets, academia and industry have begun developing chemical probes for their preclinical target validation.A chemical probe for the TAF1/TAF1L bromodomains was designed from a naphthyridinone scaffold. Statistical analysis was used to establish a relationship between permeability and pKa and, in turn, guide the optimization of permeability on the series. The developed probe molecule shows excellent potency (TAF1(2) pKD = 9.1), selectivity over the BET bromodomains (1000-fold) and other non-BET bromodomains where tested (?50-fold), improved permeability (62 nm/s), and represents a novel chemotype for TAF1/TAF1L inhibitors. From here, the concept of conserved water interactions was explored in an attempt to further increase non-BET bromodomain selectivity for TAF1(2).A BRD7/9 template was then selected to explore the concept of bromodomain selectivity through conserved water interactions more extensively. A novel butyl acetylated Lys methyl mimetic motif was discovered and utilized to produce a selective BRD7/9 chemical probe with accompanying negative control. The broader applicability of the butyl motif was then demonstrated across a variety of scaffolds to enhance selectivity for BRD7/9 in a predictable manner.","abstract_html":"This thesis describes the design and synthesis of chemical probes for non-BET bromodomains.Studies have shown that inhibition of the BET bromodomains leads to profound activity in immuno-inflammation and oncology disease settings, with several BET bromodomain inhibitors entering the clinic. The validation of this new target class has led to a surge of interest in the remaining 53 non-BET bromodomains. Whilst the majority of non-BET bromodomains have been implicated in disease pathways, the biological role they play in mediating disease states is unknown. To help delineate the function of the non-BET bromodomains in disease, and establish their potential as therapeutic targets, academia and industry have begun developing chemical probes for their preclinical target validation.A chemical probe for the TAF1/TAF1L bromodomains was designed from a naphthyridinone scaffold. Statistical analysis was used to establish a relationship between permeability and pKa and, in turn, guide the optimization of permeability on the series. The developed probe molecule shows excellent potency (TAF1(2) pKD = 9.1), selectivity over the BET bromodomains (1000-fold) and other non-BET bromodomains where tested (?50-fold), improved permeability (62 nm/s), and represents a novel chemotype for TAF1/TAF1L inhibitors. From here, the concept of conserved water interactions was explored in an attempt to further increase non-BET bromodomain selectivity for TAF1(2).A BRD7/9 template was then selected to explore the concept of bromodomain selectivity through conserved water interactions more extensively. A novel butyl acetylated Lys methyl mimetic motif was discovered and utilized to produce a selective BRD7/9 chemical probe with accompanying negative control. The broader applicability of the butyl motif was then demonstrated across a variety of scaffolds to enhance selectivity for BRD7/9 in a predictable manner.","abstract_has_math":false,"creators":["Clegg, Michael A."],"institution":"University of Strathclyde","degree_name":"phd","degree_level":"doctoral-pg","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Tomkinson, Nick","Humphreys, Philip","Liwicki, Gemma"],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019","date_published":"2019","updated_at":"2026-11-19T16:23:46Z","subjects":[],"languages":[],"rights":[],"rights_urls":["https://stax.strath.ac.uk/thesis_copyright_statement/"],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.48730/s93p-pj47"],"render_values":[{"text":"10.48730/s93p-pj47","href":"https://doi.org/10.48730/s93p-pj47","code":true}]},{"key":"dc:identifier","label":"Identifier","values":["T16430"],"render_values":[{"text":"T16430","href":null,"code":true}]}],"person_identifier_entries":[{"key":"dc:creator.authoridentifier","label":"Author Identifier","values":["201654328"],"render_values":[{"text":"201654328","href":null,"code":true}]}]},"links":{"outbound_url":"https://stax.strath.ac.uk/concern/theses/d217qq024","outbound_label":"Repository record","outbound_source":"dc:identifier.uri","record_url":"https://stax.strath.ac.uk/concern/theses/d217qq024","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://stax.strath.ac.uk/catalog/oai?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Astrathclyde%3Ad217qq024","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Tomkinson, Nick","Humphreys, Philip","Liwicki, Gemma"]},{"key":"dc:creator","label":"Author","values":["Clegg, Michael A."]},{"key":"dc:creator.authoridentifier","label":"Author Identifier","values":["201654328"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.issued","label":"Date","values":["2019"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Department of Pure and Applied Chemistry"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Strathclyde"]},{"key":"dc:relation.uri","label":"Dc Relation URI","values":["https://stax.strath.ac.uk/downloads/5m60qs347"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["doctoral-pg"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["phd"]},{"key":"dc:type.uri","label":"Dc Type URI","values":["http://purl.org/coar/resource_type/c_db06"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights.uri","label":"Rights URI","values":["https://stax.strath.ac.uk/thesis_copyright_statement/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["T16430"]},{"key":"dc:identifier.doi","label":"DOI","values":["10.48730/s93p-pj47"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://stax.strath.ac.uk/concern/theses/d217qq024"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Previously held under moratorium in Chemistry department (GSK) from 17th June 2020 until 23rd November 2022.","The confidentiality statement on each page of this thesis DOES NOT apply","This thesis describes the design and synthesis of chemical probes for non-BET bromodomains.Studies have shown that inhibition of the BET bromodomains leads to profound activity in immuno-inflammation and oncology disease settings, with several BET bromodomain inhibitors entering the clinic. The validation of this new target class has led to a surge of interest in the remaining 53 non-BET bromodomains. Whilst the majority of non-BET bromodomains have been implicated in disease pathways, the biological role they play in mediating disease states is unknown. To help delineate the function of the non-BET bromodomains in disease, and establish their potential as therapeutic targets, academia and industry have begun developing chemical probes for their preclinical target validation.A chemical probe for the TAF1/TAF1L bromodomains was designed from a naphthyridinone scaffold. Statistical analysis was used to establish a relationship between permeability and pKa and, in turn, guide the optimization of permeability on the series. The developed probe molecule shows excellent potency (TAF1(2) pKD = 9.1), selectivity over the BET bromodomains (1000-fold) and other non-BET bromodomains where tested (?50-fold), improved permeability (62 nm/s), and represents a novel chemotype for TAF1/TAF1L inhibitors. From here, the concept of conserved water interactions was explored in an attempt to further increase non-BET bromodomain selectivity for TAF1(2).A BRD7/9 template was then selected to explore the concept of bromodomain selectivity through conserved water interactions more extensively. A novel butyl acetylated Lys methyl mimetic motif was discovered and utilized to produce a selective BRD7/9 chemical probe with accompanying negative control. The broader applicability of the butyl motif was then demonstrated across a variety of scaffolds to enhance selectivity for BRD7/9 in a predictable manner."]},{"key":"dc:description.abstract","label":"Abstract","values":["This thesis describes the design and synthesis of chemical probes for non-BET bromodomains.Studies have shown that inhibition of the BET bromodomains leads to profound activity in immuno-inflammation and oncology disease settings, with several BET bromodomain inhibitors entering the clinic. The validation of this new target class has led to a surge of interest in the remaining 53 non-BET bromodomains. Whilst the majority of non-BET bromodomains have been implicated in disease pathways, the biological role they play in mediating disease states is unknown. To help delineate the function of the non-BET bromodomains in disease, and establish their potential as therapeutic targets, academia and industry have begun developing chemical probes for their preclinical target validation.A chemical probe for the TAF1/TAF1L bromodomains was designed from a naphthyridinone scaffold. Statistical analysis was used to establish a relationship between permeability and pKa and, in turn, guide the optimization of permeability on the series. The developed probe molecule shows excellent potency (TAF1(2) pKD = 9.1), selectivity over the BET bromodomains (1000-fold) and other non-BET bromodomains where tested (?50-fold), improved permeability (62 nm/s), and represents a novel chemotype for TAF1/TAF1L inhibitors. From here, the concept of conserved water interactions was explored in an attempt to further increase non-BET bromodomain selectivity for TAF1(2).A BRD7/9 template was then selected to explore the concept of bromodomain selectivity through conserved water interactions more extensively. A novel butyl acetylated Lys methyl mimetic motif was discovered and utilized to produce a selective BRD7/9 chemical probe with accompanying negative control. The broader applicability of the butyl motif was then demonstrated across a variety of scaffolds to enhance selectivity for BRD7/9 in a predictable manner."]},{"key":"dc:title","label":"Title","values":["The design and synthesis of chemical probes for non-BET bromodomains"]}]}],"canonical_facts":{"dc:contributor.advisor":["Tomkinson, Nick","Humphreys, Philip","Liwicki, Gemma"],"dc:creator":["Clegg, Michael A."],"dc:creator.authoridentifier":["201654328"],"dc:date.issued":["2019"],"dc:description":["Previously held under moratorium in Chemistry department (GSK) from 17th June 2020 until 23rd November 2022.","The confidentiality statement on each page of this thesis DOES NOT apply","This thesis describes the design and synthesis of chemical probes for non-BET bromodomains.Studies have shown that inhibition of the BET bromodomains leads to profound activity in immuno-inflammation and oncology disease settings, with several BET bromodomain inhibitors entering the clinic. The validation of this new target class has led to a surge of interest in the remaining 53 non-BET bromodomains. Whilst the majority of non-BET bromodomains have been implicated in disease pathways, the biological role they play in mediating disease states is unknown. To help delineate the function of the non-BET bromodomains in disease, and establish their potential as therapeutic targets, academia and industry have begun developing chemical probes for their preclinical target validation.A chemical probe for the TAF1/TAF1L bromodomains was designed from a naphthyridinone scaffold. Statistical analysis was used to establish a relationship between permeability and pKa and, in turn, guide the optimization of permeability on the series. The developed probe molecule shows excellent potency (TAF1(2) pKD = 9.1), selectivity over the BET bromodomains (1000-fold) and other non-BET bromodomains where tested (?50-fold), improved permeability (62 nm/s), and represents a novel chemotype for TAF1/TAF1L inhibitors. From here, the concept of conserved water interactions was explored in an attempt to further increase non-BET bromodomain selectivity for TAF1(2).A BRD7/9 template was then selected to explore the concept of bromodomain selectivity through conserved water interactions more extensively. A novel butyl acetylated Lys methyl mimetic motif was discovered and utilized to produce a selective BRD7/9 chemical probe with accompanying negative control. The broader applicability of the butyl motif was then demonstrated across a variety of scaffolds to enhance selectivity for BRD7/9 in a predictable manner."],"dc:description.abstract":["This thesis describes the design and synthesis of chemical probes for non-BET bromodomains.Studies have shown that inhibition of the BET bromodomains leads to profound activity in immuno-inflammation and oncology disease settings, with several BET bromodomain inhibitors entering the clinic. The validation of this new target class has led to a surge of interest in the remaining 53 non-BET bromodomains. Whilst the majority of non-BET bromodomains have been implicated in disease pathways, the biological role they play in mediating disease states is unknown. To help delineate the function of the non-BET bromodomains in disease, and establish their potential as therapeutic targets, academia and industry have begun developing chemical probes for their preclinical target validation.A chemical probe for the TAF1/TAF1L bromodomains was designed from a naphthyridinone scaffold. Statistical analysis was used to establish a relationship between permeability and pKa and, in turn, guide the optimization of permeability on the series. The developed probe molecule shows excellent potency (TAF1(2) pKD = 9.1), selectivity over the BET bromodomains (1000-fold) and other non-BET bromodomains where tested (?50-fold), improved permeability (62 nm/s), and represents a novel chemotype for TAF1/TAF1L inhibitors. From here, the concept of conserved water interactions was explored in an attempt to further increase non-BET bromodomain selectivity for TAF1(2).A BRD7/9 template was then selected to explore the concept of bromodomain selectivity through conserved water interactions more extensively. A novel butyl acetylated Lys methyl mimetic motif was discovered and utilized to produce a selective BRD7/9 chemical probe with accompanying negative control. The broader applicability of the butyl motif was then demonstrated across a variety of scaffolds to enhance selectivity for BRD7/9 in a predictable manner."],"dc:identifier":["T16430"],"dc:identifier.doi":["10.48730/s93p-pj47"],"dc:identifier.uri":["https://stax.strath.ac.uk/concern/theses/d217qq024"],"dc:publisher.department":["Department of Pure and Applied Chemistry"],"dc:publisher.institution":["University of Strathclyde"],"dc:relation.uri":["https://stax.strath.ac.uk/downloads/5m60qs347"],"dc:rights.uri":["https://stax.strath.ac.uk/thesis_copyright_statement/"],"dc:title":["The design and synthesis of chemical probes for non-BET bromodomains"],"dc:type.qualificationlevel":["doctoral-pg"],"dc:type.qualificationname":["phd"],"dc:type.uri":["http://purl.org/coar/resource_type/c_db06"]},"updated_at":"2026-11-19T16:23:46Z"}